cancer

Arginine-chitosan nanoparticles for siRNA transport
Small interfering RNAs (siRNAs) can be used as in gene therapies for e.g. cancers such as leukemia. However, the application of these is limited by a lack of efficient drug delivery. Therefore, in the presented study, chitosan was functionalized with arginine to form nanoparticles, loaded with siRNA, and their properties as siRNA vectors were investigated.

Carboxymethyl chitosan for treatment of liver carcinomas
Hepatocellular carcinoma is a solid tumor that exhibits severe angiogenesis, cell cycle dysregulation, and evasion of apoptosis. Late diagnosis in a large proportion of patients is making the carcinomas inoperable, and various chemotherapeutic agents are used. Due to the numerous side effects of known chemotherapeutic agents, intensive research is performed on the use of natural products and their synthetic analogues. The authors of the presented study investigated the effect of carboxymethyl chitosan oligosaccharides on the growth of hepatocellular tumors in mice.

Chitosan and curcumin for treatment of glaucoma or cancer
Glaucoma is a group of diseases of the eye with damaged optic nerve and retina in advanced stages, possibly leading to blindness. One of the causes is increased intraocular pressure. Here, we present two publications, which investigated the combination of chitosan and curcumin for treatment of glaucoma and cancer patients.

Gold nanoparticles with chitosan
There are many potential applications of gold nanoparticles in medicine. Gold nanoparticles are already being used in diagnostics, as in pregnancy or HIV tests [1]. Research on the use as a contrast agent for the localization of cancer cells and as a drug delivery system for targeted release at site of action. The surface properties of gold are optimal for functionalization, e.g. with chitosan.

Drug delivery systems with chitosan
Biological barriers can limit the availability of a therapeutic agent in the target tissue. Drug delivery systems overcome these limitations to transport the correct dose of drug to its target site. The biopolymer chitosan has great potential for the development of innovative drug delivery systems. We present two articles that explore the treatment of cancer and noise-induced hearing loss with chitosan-based drug delivery systems.

Publications in July & August 2016 - drug delivery systems
Today´s topic is chitosan for drug delivery systems. In July and August 2016, 33 articles about chitosan combined with drug delivery systems were published. As might be expected, top publisher are China (13 articles), United States (5) and India (4). The articles investigated drug release by chitosan-based micro- or nanoparticles, hydrogels and nanocomposites. Thereby controlled release of cytostatics, proteins or peptides was mainly studied. (Source: www.gopubmed.org)

Publications in January 2016
In January were 77 publications with chitosan topics published. In addition to China (26) and the United States (11), Egypt (6) is on the third place of nations with the most publications.

Publication May and June 2013
231 articles about chitosan and chitosan derivatives have been published in May and June 2013. The main topics focused on animal and human studies and on chitosan-based nanoparticles and pharmaceutical preparations. Moreover, the physico-chemical properties and pH sensitivity of various chitosan derivatives were intensively studied. Among the top nations of chitosan research are again: China (76 articles), USA (30) and India (14).

Publications in January 2011
Starting in a new year in January 2011 92 articles about chitosan and its derivates were published. The top themes in the last month were evaluation studies, studies in tissues and about nanoparticle with 26, 25 and 21 publications.

Publications in December 2010
In December 2010 116 articles dealing with chitosan or chitosan derivates were published. With 31 publications about chitosan China is the country which publicized the most ones followed by USA with 10 publications and India with 9. There chitosan nanoparticles, evaluation studies and pharmaceutical preparations were of most interest (37, 34 and 33 publications).

Publications in September 2010
Besides interesting conferences like the ESB Meeting (European Conference on Biomaterials) from September 11 to 15 in Tampere, Finland many international articles about the application of chitosan appeared. As usual, some interesting papers will be presented.

Current articles about chitosannanoparticles
In the first two months of this year numerous articles about chitosannanoparticles has been published into the following journals: biomaterials [6], biomed mater res a [2], j mater sci-mater m [2], langmuir [2], biomacromolecules [2]. The Authors are from Asia, Europe and Northamerica.

Publications in January 2009 - chitosan application and cancer
Starting in a new year, in January 2009 many articles about chitosan and its derivates were published. Here you have an overview about the top themes into the last month.